190 related articles for article (PubMed ID: 7776369)
1. Towards structure-based drug design: crystal structure of a multisubstrate adduct complex of glycinamide ribonucleotide transformylase at 1.96 A resolution.
Klein C; Chen P; Arevalo JH; Stura EA; Marolewski A; Warren MS; Benkovic SJ; Wilson IA
J Mol Biol; 1995 May; 249(1):153-75. PubMed ID: 7776369
[TBL] [Abstract][Full Text] [Related]
2. Rational design, synthesis, evaluation, and crystal structure of a potent inhibitor of human GAR Tfase: 10-(trifluoroacetyl)-5,10-dideazaacyclic-5,6,7,8-tetrahydrofolic acid.
Zhang Y; Desharnais J; Marsilje TH; Li C; Hedrick MP; Gooljarsingh LT; Tavassoli A; Benkovic SJ; Olson AJ; Boger DL; Wilson IA
Biochemistry; 2003 May; 42(20):6043-56. PubMed ID: 12755606
[TBL] [Abstract][Full Text] [Related]
3. Unexpected formation of an epoxide-derived multisubstrate adduct inhibitor on the active site of GAR transformylase.
Greasley SE; Marsilje TH; Cai H; Baker S; Benkovic SJ; Boger DL; Wilson IA
Biochemistry; 2001 Nov; 40(45):13538-47. PubMed ID: 11695901
[TBL] [Abstract][Full Text] [Related]
4. X-ray crystal structure of glycinamide ribonucleotide synthetase from Escherichia coli.
Wang W; Kappock TJ; Stubbe J; Ealick SE
Biochemistry; 1998 Nov; 37(45):15647-62. PubMed ID: 9843369
[TBL] [Abstract][Full Text] [Related]
5. A pH-dependent stabilization of an active site loop observed from low and high pH crystal structures of mutant monomeric glycinamide ribonucleotide transformylase at 1.8 to 1.9 A.
Su Y; Yamashita MM; Greasley SE; Mullen CA; Shim JH; Jennings PA; Benkovic SJ; Wilson IA
J Mol Biol; 1998 Aug; 281(3):485-99. PubMed ID: 9698564
[TBL] [Abstract][Full Text] [Related]
6. Crystal structures of human GAR Tfase at low and high pH and with substrate beta-GAR.
Zhang Y; Desharnais J; Greasley SE; Beardsley GP; Boger DL; Wilson IA
Biochemistry; 2002 Dec; 41(48):14206-15. PubMed ID: 12450384
[TBL] [Abstract][Full Text] [Related]
7. A rapid screen of active site mutants in glycinamide ribonucleotide transformylase.
Warren MS; Marolewski AE; Benkovic SJ
Biochemistry; 1996 Jul; 35(27):8855-62. PubMed ID: 8688421
[TBL] [Abstract][Full Text] [Related]
8. New insights into inhibitor design from the crystal structure and NMR studies of Escherichia coli GAR transformylase in complex with beta-GAR and 10-formyl-5,8,10-trideazafolic acid.
Greasley SE; Yamashita MM; Cai H; Benkovic SJ; Boger DL; Wilson IA
Biochemistry; 1999 Dec; 38(51):16783-93. PubMed ID: 10606510
[TBL] [Abstract][Full Text] [Related]
9. Catalytic mechanism of Escherichia coli glycinamide ribonucleotide transformylase probed by site-directed mutagenesis and pH-dependent studies.
Shim JH; Benkovic SJ
Biochemistry; 1999 Aug; 38(31):10024-31. PubMed ID: 10433709
[TBL] [Abstract][Full Text] [Related]
10. The human glycinamide ribonucleotide transformylase domain: purification, characterization, and kinetic mechanism.
Caperelli CA; Giroux EL
Arch Biochem Biophys; 1997 May; 341(1):98-103. PubMed ID: 9143358
[TBL] [Abstract][Full Text] [Related]
11. Proton transfer dynamics of GART: the pH-dependent catalytic mechanism examined by electrostatic calculations.
Morikis D; Elcock AH; Jennings PA; McCammon JA
Protein Sci; 2001 Nov; 10(11):2379-92. PubMed ID: 11604543
[TBL] [Abstract][Full Text] [Related]
12. Crystal structure of glycinamide ribonucleotide transformylase from Escherichia coli at 3.0 A resolution. A target enzyme for chemotherapy.
Chen P; Schulze-Gahmen U; Stura EA; Inglese J; Johnson DL; Marolewski A; Benkovic SJ; Wilson IA
J Mol Biol; 1992 Sep; 227(1):283-92. PubMed ID: 1522592
[TBL] [Abstract][Full Text] [Related]
13. Structure of avian AICAR transformylase with a multisubstrate adduct inhibitor beta-DADF identifies the folate binding site.
Wolan DW; Greasley SE; Wall MJ; Benkovic SJ; Wilson IA
Biochemistry; 2003 Sep; 42(37):10904-14. PubMed ID: 12974624
[TBL] [Abstract][Full Text] [Related]
14. Structures of apo and complexed Escherichia coli glycinamide ribonucleotide transformylase.
Almassy RJ; Janson CA; Kan CC; Hostomska Z
Proc Natl Acad Sci U S A; 1992 Jul; 89(13):6114-8. PubMed ID: 1631098
[TBL] [Abstract][Full Text] [Related]
15. Structural insights into the human and avian IMP cyclohydrolase mechanism via crystal structures with the bound XMP inhibitor.
Wolan DW; Cheong CG; Greasley SE; Wilson IA
Biochemistry; 2004 Feb; 43(5):1171-83. PubMed ID: 14756553
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological evaluation of N-[4-[5-(2,4-diamino-6-oxo-1,6-dihydropyrimidin-5-yl)-2-(2,2,2-trifluoroacetyl)pentyl]benzoyl]-L-glutamic acid as a potential inhibitor of GAR Tfase and the de novo purine biosynthetic pathway.
Cheng H; Hwang I; Chong Y; Tavassoli A; Webb ME; Zhang Y; Wilson IA; Benkovic SJ; Boger DL
Bioorg Med Chem; 2005 May; 13(10):3593-9. PubMed ID: 15848772
[TBL] [Abstract][Full Text] [Related]
17. The apo and ternary complex structures of a chemotherapeutic target: human glycinamide ribonucleotide transformylase.
Dahms TE; Sainz G; Giroux EL; Caperelli CA; Smith JL
Biochemistry; 2005 Jul; 44(29):9841-50. PubMed ID: 16026156
[TBL] [Abstract][Full Text] [Related]
18. 10-Formyl-5,10-dideaza-acyclic-5,6,7,8-tetrahydrofolic acid (10-formyl-DDACTHF): a potent cytotoxic agent acting by selective inhibition of human GAR Tfase and the de novo purine biosynthetic pathway.
Marsilje TH; Labroli MA; Hedrick MP; Jin Q; Desharnais J; Baker SJ; Gooljarsingh LT; Ramcharan J; Tavassoli A; Zhang Y; Wilson IA; Beardsley GP; Benkovic SJ; Boger DL
Bioorg Med Chem; 2002 Aug; 10(8):2739-49. PubMed ID: 12057663
[TBL] [Abstract][Full Text] [Related]
19. Tight binding of folate substrates and inhibitors to recombinant mouse glycinamide ribonucleotide formyltransferase.
Sanghani SP; Moran RG
Biochemistry; 1997 Aug; 36(34):10506-16. PubMed ID: 9265631
[TBL] [Abstract][Full Text] [Related]
20. Molecular structure of Escherichia coli PurT-encoded glycinamide ribonucleotide transformylase.
Thoden JB; Firestine S; Nixon A; Benkovic SJ; Holden HM
Biochemistry; 2000 Aug; 39(30):8791-802. PubMed ID: 10913290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
